Ashok Agarwal; Florence Boitrelle; Panagiotis Drakopoulos; Hassan Nooman Sallam; Ramadan Saleh. About the Author. 2025 .

Ashok Agarwal, Florence Boitrelle, Panagiotis Drakopoulos, Hassan Nooman Sallam, Ramadan Saleh. About the Author. . 2025; ():.

Ashok Agarwal; Florence Boitrelle; Panagiotis Drakopoulos; Hassan Nooman Sallam; Ramadan Saleh. 2025. "About the Author." , no. : .

Mohamed E. Mahmoud; Nesma K. Kamel; Mohamed F. Amira; Nesma A. Fekry. Nitrate removal from wastewater by a novel co-biochar from guava seeds/beetroot peels-functionalized-Mg/Al double-layered hydroxide. Separation and Purification Technology 2024, 344 .

Mohamed E. Mahmoud, Nesma K. Kamel, Mohamed F. Amira, Nesma A. Fekry. Nitrate removal from wastewater by a novel co-biochar from guava seeds/beetroot peels-functionalized-Mg/Al double-layered hydroxide. Separation and Purification Technology. 2024; 344 ():.

Mohamed E. Mahmoud; Nesma K. Kamel; Mohamed F. Amira; Nesma A. Fekry. 2024. "Nitrate removal from wastewater by a novel co-biochar from guava seeds/beetroot peels-functionalized-Mg/Al double-layered hydroxide." Separation and Purification Technology 344, no. : .

Aim: The management of type 2 diabetes mellitus is affected by the presence of comorbidities. This meta-analysis aimed to determine how likely it is for individuals with type 2 diabetes in the Middle East and North Africa (MENA) to be living with additional chronic health conditions. Methods: We searched for studies published from January 2010 to December 2020 in PubMed, Ovid MEDLINE®, Cochrane CENTRAL, Scopus, and Web of Science. Studies of adults with type 2 diabetes in the MENA region were included. We performed a random-effects meta-analysis of single proportions to calculate each comorbidity's overall prevalence/co-prevalence. Results: Statistically significant co-prevalence was detected at p < 0.01 for angina (pooled proportion: 0.24, 95% CI: 0.06, 0.49), cerebrovascular accident (pooled proportion: 0.16, 95% CI: 0.08, 0.26), coronary artery disease (pooled proportion: 0.25, 95% CI: 0.16, 0.35), coronary heart disease (pooled proportion: 0.05, 95% CI: 0.01, 0.12), peripheral vascular disease (pooled proportion: 0.19, 95% CI: 0.13, 0.26), hypertension (pooled proportion: 0.56, 95% CI: 0.43, 0.69), renal impairment (pooled proportion: 0.19, 95% CI: 0.10, 0.29), in addition to hyperlipidemia and overweight/obesity. Conclusion: There is evidence of co-prevalence of several comorbidities in patients with type 2 diabetes. This highlights the importance of enhancing communication among healthcare professionals to develop the optimal management plan for each patient.

Samir Assaad Khalil; Sami Azar; Khadija Hafidh; George Ayad; Mohamed Safwat. Prevalence and Co-prevalence of Comorbidities among Patients with Type 2 Diabetes Mellitus in the MENA Region: A Systematic Review. Current Diabetes Reviews 2024, 20, 1 -1.

Samir Assaad Khalil, Sami Azar, Khadija Hafidh, George Ayad, Mohamed Safwat. Prevalence and Co-prevalence of Comorbidities among Patients with Type 2 Diabetes Mellitus in the MENA Region: A Systematic Review. Current Diabetes Reviews. 2024; 20 (7):1-1.

Samir Assaad Khalil; Sami Azar; Khadija Hafidh; George Ayad; Mohamed Safwat. 2024. "Prevalence and Co-prevalence of Comorbidities among Patients with Type 2 Diabetes Mellitus in the MENA Region: A Systematic Review." Current Diabetes Reviews 20, no. 7: 1-1.